Cooper Companies completes acquisition of Sauflon

The Cooper Companies, Inc. recently completed its acquisition of Sauflon Pharmaceuticals Limited in a transaction valued at approximately $1.2 billion, expanding CooperVision’s range of contact lens offerings.

Pleasanton, CA-The Cooper Companies, Inc. recently completed its acquisition of Sauflon Pharmaceuticals Limited in a transaction valued at approximately $1.2 billion, expanding CooperVision’s range of contact lens offerings.

Sauflon joins U.S. contact lens market

“We’re approaching the daily disposables category with a new, multi-tier model. By adding the Sauflon portfolio to our already-strong MyDay and Proclear brand choices, we’re bringing forward multiple contact lens families designed and marketed for distinct wearer segments,” says Daniel G. McBride, president of CooperVision, Inc. “This approach to the market provides practitioners the ability to offer a daily disposable lens for every eye and every budget, which should further accelerate both practice growth and category momentum.”

According to the company, CooperVision is now working to combine both companies’ employees, processes, and pipelines. Customers should continue working with their current CooperVision and Sauflon representatives, support resources, and ordering mechanisms until advised otherwise.

Related Videos
 Valerie M. Kattouf, OD, associate professor of optometry and chief of the Dr. Robert and Lena Lewenson Center for Pediatric and Binocular Vision, Illinois College of Optometry, speaks with Optometry Times®' Alex Delaney-Gesing on key highlights and takeaways from her 2022 Vision Expo West presentation titled "Myopia Control."
Ashley Tucker, OD, FAAO, FSLS, Dipl ABO, shares highlights from her discussion titled, "Myopia management: past, present, and future," presented during this year's 115th annual SCOPA meeting.
© 2023 MJH Life Sciences

All rights reserved.